Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Data Access Guidelines
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Data Access Guidelines
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Thursday, 29 January 2015

Join the MSF Online Journal Club this week on malaria

Thursday, 29 January 2015

Latest study confirms further spread and emergence of antimalarial resistance in Southeast Asia

The latest study published in the New England Journal of Medicine, confirms that resistance to the current frontline antimalarial, artemisinin, is now present in Eastern Myanmar, Thailand and Southern Vietnam, as well as Western Cambodia.
Thursday, 29 January 2015

WHO put the spotlight on artemisinin resistance

Thursday, 29 January 2015

Researchers identify a molecular marker for parasites resistant to malaria treatment

Thursday, 29 January 2015

Two new tests distinguish drug-resistant from drug-susceptible parasites

Thursday, 29 January 2015

The Great Malaria Debate at JITTM Bangkok

Thursday, 29 January 2015

WHO World Health Day spotlight on vector-borne diseases

Thursday, 29 January 2015

Prof. Nick White prepares seminar on antimalarial resistance

Thursday, 29 January 2015

Join us at 6th MIM Pan-African Malaria Conference in Durban, South Africa

Thursday, 29 January 2015

WWARN at ASTMH Annual Meeting 2013

Thursday, 29 January 2015

Challenges in antimalarial drug resistance

Thursday, 29 January 2015

African clinical trials awarded €683 million European Union (EU) investment

Thursday, 29 January 2015

PLOS Medicine publishes paper recommending review of DP antimalarial dosing

Thursday, 29 January 2015

Have you read the WHO World Malaria Report?

Thursday, 29 January 2015

Acting Director announced at the WHO Global Malaria Programme

Thursday, 29 January 2015

A quick overview of Malaria funding in the US

Thursday, 29 January 2015

CDC providing malaria drug resistance testing services

Thursday, 29 January 2015

Global Fund forecasts $1.6 billion in available funds for 2012-2014

Thursday, 29 January 2015

New study suggests malaria deaths may be underestimated

Thursday, 29 January 2015

Counterfeit artesunate risks patient’s life

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Current page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page ››
  • Last page Last »

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2026 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use